Literature DB >> 3940018

Adhesion of pathogenic Candida species to host surfaces.

L J Douglas1.   

Abstract

Candida infections are becoming increasingly important in compromised hosts. The pathogenic Candida species vary in their ability to adhere to mucosal and other surfaces and there is a clear correlation between adhesion and virulence. Adhesion mechanisms of the most pathogenic species, Candida albicans, are being studied in detail.

Entities:  

Mesh：

Year:  1985        PMID： 3940018

Source DB:  PubMed          Journal:  Microbiol Sci        ISSN： 0265-1351


  6 in total

1.  Effect of Candida albicans cell wall components on the adhesion of the fungus to human and murine vaginal mucosa.

Authors:  N Lehrer; E Segal; H Lis; Y Gov
Journal:  Mycopathologia       Date:  1988-05       Impact factor: 2.574

Review 2.  Candida mannan: chemistry, suppression of cell-mediated immunity, and possible mechanisms of action.

Authors:  R D Nelson; N Shibata; R P Podzorski; M J Herron
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

3.  Variation in adhesion and cell surface hydrophobicity in Candida albicans white and opaque phenotypes.

Authors:  M J Kennedy; A L Rogers; L R Hanselmen; D R Soll; R J Yancey
Journal:  Mycopathologia       Date:  1988-06       Impact factor: 2.574

4.  Characterization of genetically distinct subgroup of Candida albicans strains isolated from oral cavities of patients infected with human immunodeficiency virus.

Authors:  M McCullough; B Ross; P Reade
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

5.  Characterization of a major cell wall antigen and potential adhesin in three strains of Candida albicans.

Authors:  W Jenq; C L Chen; C C Chang; R F Crang
Journal:  Arch Microbiol       Date:  1994       Impact factor: 2.552

6.  Candida albicans exhibit two classes of cell surface binding sites for serum albumin defined by their affinity, abundance and prospective role in interkingdom signalling.

Authors:  Claire Teevan-Hanman; Paul O'Shea
Journal:  PLoS One       Date:  2021-07-19       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.